OM PE Ratio & Valuation,Is OM Overvalued

OM Relative Valuation

OM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, OM is overvalued; if below, it's undervalued.

Historical Valuation

Outset Medical Inc (OM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.64 is considered Undervalued compared with the five-year average of -8.47. The fair price of Outset Medical Inc (OM) is between 34.10 to 116.59 according to relative valuation methord. Compared to the current price of 4.17 USD , Outset Medical Inc is Undervalued By 87.77%.

Relative Value

Fair Zone

34.10-116.59

Current Price：4.17

87.77%

Undervalued

-1.37

0.01

EV/EBITDA

Outset Medical Inc. (OM) has a current EV/EBITDA of 0.01. The 5-year average EV/EBITDA is -7.67. The thresholds are as follows: Strongly Undervalued below -20.33, Undervalued between -20.33 and -14.00, Fairly Valued between -1.34 and -14.00, Overvalued between -1.34 and 4.99, and Strongly Overvalued above 4.99. The current Forward EV/EBITDA of 0.01 falls within the Overvalued range.

0.01

EV/EBIT

Outset Medical Inc. (OM) has a current EV/EBIT of 0.01. The 5-year average EV/EBIT is -6.82. The thresholds are as follows: Strongly Undervalued below -17.97, Undervalued between -17.97 and -12.39, Fairly Valued between -1.24 and -12.39, Overvalued between -1.24 and 4.34, and Strongly Overvalued above 4.34. The current Forward EV/EBIT of 0.01 falls within the Overvalued range.

0.64

Outset Medical Inc. (OM) has a current PS of 0.64. The 5-year average PS is 8.08. The thresholds are as follows: Strongly Undervalued below -7.64, Undervalued between -7.64 and 0.22, Fairly Valued between 15.94 and 0.22, Overvalued between 15.94 and 23.81, and Strongly Overvalued above 23.81. The current Forward PS of 0.64 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Outset Medical Inc. (OM) has a current P/OCF of 0.00. The 5-year average P/OCF is -6.45. The thresholds are as follows: Strongly Undervalued below -23.19, Undervalued between -23.19 and -14.82, Fairly Valued between 1.92 and -14.82, Overvalued between 1.92 and 10.29, and Strongly Overvalued above 10.29. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Outset Medical Inc. (OM) has a current P/FCF of 0.00. The 5-year average P/FCF is -7.07. The thresholds are as follows: Strongly Undervalued below -23.92, Undervalued between -23.92 and -15.50, Fairly Valued between 1.36 and -15.50, Overvalued between 1.36 and 9.78, and Strongly Overvalued above 9.78. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Outset Medical Inc (OM) has a current Price-to-Book (P/B) ratio of 0.54. Compared to its 3-year average P/B ratio of 2.29 , the current P/B ratio is approximately -76.58% higher. Relative to its 5-year average P/B ratio of 3.37, the current P/B ratio is about -84.07% higher. Outset Medical Inc (OM) has a Forward Free Cash Flow (FCF) yield of approximately -71.05%. Compared to its 3-year average FCF yield of -103.78%, the current FCF yield is approximately -31.54% lower. Relative to its 5-year average FCF yield of -65.46% , the current FCF yield is about 8.54% lower.

0.51

P/B

Median3y

2.29

Median5y

3.37

-71.05

FCF Yield

Median3y

-103.78

Median5y

-65.46

Competitors Valuation Multiple

The average P/S ratio for OM's competitors is , providing a benchmark for relative valuation. Outset Medical Inc Corp (OM) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 2.67%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of OM decreased by 76.16% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 28.67M to 29.43M.

The secondary factor is the Margin Expansion, contributed -37.82%to the performance.

Overall, the performance of OM in the past 1 year is driven by Revenue Growth. Which is more sustainable.

2.67%

28.67M → 29.43M

Revenue Growth

-37.82%

-97.47 → -60.61

Margin Expansion

-41.01%

-0.89 → -0.52

P/E Change

-76.16%

16.65 → 3.97

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Outset Medical Inc (OM) currently overvalued or undervalued?

What is Outset Medical Inc (OM) fair value?

OM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Outset Medical Inc (OM) is between 34.10 to 116.59 according to relative valuation methord.

How does OM's valuation metrics compare to the industry average?

What is the current P/B ratio for Outset Medical Inc (OM) as of Dec 16 2025?

As of Dec 16 2025, Outset Medical Inc (OM) has a P/B ratio of 0.54. This indicates that the market values OM at 0.54 times its book value.

What is the current FCF Yield for Outset Medical Inc (OM) as of Dec 16 2025?

As of Dec 16 2025, Outset Medical Inc (OM) has a FCF Yield of -71.05%. This means that for every dollar of Outset Medical Inc’s market capitalization, the company generates -71.05 cents in free cash flow.

What is the current Forward P/E ratio for Outset Medical Inc (OM) as of Dec 16 2025?

As of Dec 16 2025, Outset Medical Inc (OM) has a Forward P/E ratio of -1.44. This means the market is willing to pay $-1.44 for every dollar of Outset Medical Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Outset Medical Inc (OM) as of Dec 16 2025?

As of Dec 16 2025, Outset Medical Inc (OM) has a Forward P/S ratio of 0.64. This means the market is valuing OM at $0.64 for every dollar of expected revenue over the next 12 months.

OM Valuation